Abstract: A display device includes a voltage wiring pattern in a non-display area and connected to a display area, and between a pad area and the voltage wiring pattern, a metal wiring pattern in the non-display area and connecting the pad area to the voltage wiring pattern, and a sealing member between the pad area and the voltage wiring pattern, and coupling the display panel to an encapsulation substrate. The metal wiring pattern including a lead-in portion connected to the pad area, an overlapping portion overlapping the sealing member, and a connection portion connecting the overlapping portion to the voltage wiring pattern. The overlapping portion includes a first portion corresponding to the lead-in portion, a second portion corresponding to the connection portion, and a third portion extending from the second portion in a direction away from the first portion.

Abstract: A display device includes a voltage wiring pattern in a non-display area and connected to a display area, and between a pad area and the voltage wiring pattern, a metal wiring pattern in the non-display area and connecting the pad area to the voltage wiring pattern, and a sealing member between the pad area and the voltage wiring pattern, and coupling the display panel to an encapsulation substrate. The metal wiring pattern including a lead-in portion connected to the pad area, an overlapping portion overlapping the sealing member, and a connection portion connecting the overlapping portion to the voltage wiring pattern. The overlapping portion includes a first portion corresponding to the lead-in portion, a second portion corresponding to the connection portion, and a third portion extending from the second portion in a direction away from the first portion.

Abstract: Provided is a two-liquid type hemostatic composition that may be used adjunctively during a wide range of bleeding events and surgeries, and a method for preparing the same. The two-liquid type hemostatic composition does not contain blood products, comprises a first solution containing chitosan and a second solution containing a glucose or cellulose compound, may be easily applied in a liquid form to a wound or surgical bleeding site of the human body, and may help hemostasis and recovery by immediately forming a hydrogel at the bleeding area.

Abstract: The present invention relates to a method for preparing a contact lens-shaped amniotic dressing and a contact lens-shaped amniotic dressing prepared therefrom for treating ocular surface diseases, which does not require the use of sutures or an adhesion material. The inventive contact lens-shaped amniotic dressing is capable of solving the problems associated with suturing an amniotic membrane, e.g., highly delicate surgical techniques of suturing, long surgery time, stitch abscess, granuloma formation, tissue necrosis, and discomfort of patients; and the problems associated with the use of a support, e.g., the elimination of the support by eye blinking, breaking of the support, and discomfort.

Abstract: The present invention relates to a biological implantation material and method of preparing the same, which comprises the steps of: (i) treating a tissue derived from animal or human with alcohol; (ii) contacting the said tissue with an enzyme selected from the group consisting of dispase, DNAse, RNAse and pepsin in a solvent; (iii) treating the tissue obtained in step (ii) with alkaline solution; and (iv) treating the tissue obtained in step (iii) with acid solution.